迪安诊断(300244)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300244 迪安诊断

已收盘 06-17 15:00:00

{"stockData":{"symbol":"300244","market":"SZ","secType":"STK","nameCN":"迪安诊断","latestPrice":13.14,"timestamp":1718607780000,"preClose":13.13,"halted":0,"volume":15059610,"delay":0,"floatShares":503000000,"shares":627000000,"eps":0.2718,"marketStatus":"已收盘","marketStatusCode":5,"change":0.01,"latestTime":"06-17 15:00:00","open":13,"high":13.18,"low":12.81,"amount":197000000,"amplitude":0.0282,"askPrice":13.15,"askSize":118,"bidPrice":13.14,"bidSize":65,"shortable":0,"etf":0,"ttmEps":0.2718,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1718674200000},"adr":0,"adjPreClose":13.13,"symbolType":"stock","openAndCloseTimeList":[[1718587800000,1718595000000],[1718600400000,1718607600000]],"highLimit":14.44,"lowLimit":11.82,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":626898036,"pbRate":1.1,"roa":"--","roe":"0.31%","epsLYR":0.4918,"committee":-0.059442,"marketValue":8237000000,"floatMarketCap":6608000000,"peRate":48.344369,"changeRate":0.0008,"turnoverRate":0.0299,"status":0},"requestUrl":"/m/hq/s/300244/wiki","defaultTab":"wiki","newsList":[{"id":"2441279224","title":"迪安诊断（300244）股东陈海斌质押853万股，占总股本1.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441279224","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441279224?lang=zh_cn&edition=full","pubTime":"2024-06-05 21:37","pubTimestamp":1717594625,"startTime":"0","endTime":"0","summary":"证券之星消息，迪安诊断6月5日公开信息显示，股东陈海斌向招商证券股份有限公司合计质押853.0万股，占总股本1.37%。质押详情见下表：截止本公告日，股东陈海斌已累计质押股份9467.0万股，占其持股总数的57.57%。迪安诊断主营业务：医学诊断服务、诊断技术研发、诊断产品生产及销售、CRO、司法鉴定、健康管理等领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024060500043469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK0197","BK0146","BK0186","BK0114","BK0042","300244","BK0028","BK0070"],"gpt_icon":0},{"id":"2441226704","title":"迪安诊断(300244.SZ)拟10股派0.6元 于6月13日除权除息","url":"https://stock-news.laohu8.com/highlight/detail?id=2441226704","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441226704?lang=zh_cn&edition=full","pubTime":"2024-06-05 18:36","pubTimestamp":1717583805,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迪安诊断(300244.SZ)公告，公司2023年年度权益分派拟：向全体股东每10股派发现金红利0.6元(含税)。除权除息日为：2024年6月13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1131532.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0146","BK0236","BK0114","BK0186","300244","BK0197","BK0070","BK0042"],"gpt_icon":0},{"id":"2440403788","title":"迪安诊断(300244.SZ)累计回购552.95万股 耗资1亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440403788","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440403788?lang=zh_cn&edition=full","pubTime":"2024-06-04 15:51","pubTimestamp":1717487491,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迪安诊断(300244.SZ)公告，公司截至2024年5月31日以集中竞价交易方式累计回购公司股份552.95万股，占公司目前总股本的0.88%，成交总金额为1亿元(不含交易费用)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1130675.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300244","BK0197","BK0028","BK0070","BK0114","BK0236","BK0186","BK0042","BK0146"],"gpt_icon":0},{"id":"2439455965","title":"迪安诊断：我们会进一步研究论证","url":"https://stock-news.laohu8.com/highlight/detail?id=2439455965","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439455965?lang=zh_cn&edition=full","pubTime":"2024-05-31 18:00","pubTimestamp":1717149644,"startTime":"0","endTime":"0","summary":"证券之星消息，迪安诊断05月31日在投资者关系平台上答复投资者关心的问题。非常感谢您的建议，我们会进一步研究论证。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024053100036132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","BK0028","BK0042","BK0197","BK0146","BK0070","BK0114","BK0186","300244"],"gpt_icon":0},{"id":"2434070002","title":"太平洋：给予迪安诊断买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2434070002","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434070002?lang=zh_cn&edition=full","pubTime":"2024-05-10 10:55","pubTimestamp":1715309752,"startTime":"0","endTime":"0","summary":"太平洋证券股份有限公司谭紫媚近期对迪安诊断进行研究并发布了研究报告《迪安诊断点评报告：应收回款趋势良好，一季度ICL稳定增长》，本报告对迪安诊断给出买入评级，当前股价为14.79元。最新盈利预测明细如下：该股最近90天内共有7家机构给出评级，买入评级6家，增持评级1家；过去90天内机构目标均价为19.41。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051000020668.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300244","601099"],"gpt_icon":0},{"id":"2434077908","title":"迪安诊断新注册《光学字符识别医疗报告采集系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2434077908","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434077908?lang=zh_cn&edition=full","pubTime":"2024-05-09 00:54","pubTimestamp":1715187247,"startTime":"0","endTime":"0","summary":"证券之星消息，近日迪安诊断（300244）新注册了《光学字符识别医疗报告采集系统V1.0》项目的软件著作权。今年以来迪安诊断新注册软件著作权2个，较去年同期减少了0%。结合公司2023年年报财务数据，2023年公司在研发方面投入了4.33亿元，同比减32.24%。数据来源：企查查以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050900000202.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0236","BK0070","159891","BK0042","300244","BK0197","BK0146","BK0028","BK0186"],"gpt_icon":0},{"id":"2433247198","title":"迪安诊断(300244.SZ)累计回购552.95万股 耗资1亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433247198","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433247198?lang=zh_cn&edition=full","pubTime":"2024-05-07 16:06","pubTimestamp":1715069210,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迪安诊断(300244.SZ)公告，截至2024年4月30日，公司通过回购专用证券账户以集中竞价交易方式累计回购公司股份552.95万股，占公司目前总股本的0.88%，最高成交价为18.91元/股，最低成交价为15.01元/股，成交总金额为人民币1亿元(不含交易费用)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1118149.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0197","BK0028","BK0114","300244","BK0070","BK0146","BK0236","BK0042","BK0186"],"gpt_icon":0},{"id":"2433466516","title":"迪安诊断（300244）4月30日主力资金净卖出1074.02万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433466516","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433466516?lang=zh_cn&edition=full","pubTime":"2024-05-06 09:20","pubTimestamp":1714958439,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年4月30日收盘，迪安诊断报收于14.1元，下跌3.95%，换手率4.37%，成交量21.97万手，成交额3.13亿元。近5日资金流向一览见下表：迪安诊断融资融券信息显示，融资方面，当日融资买入3188.21万元，融资偿还1428.88万元，融资净买入1759.32万元。迪安诊断主营业务：医学诊断服务、诊断技术研发、诊断产品生产及销售、CRO、司法鉴定、健康管理等领域。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050600001477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0042","BK0186","300244","BK0146","BK0028","BK0197","BK0114","BK0236"],"gpt_icon":0},{"id":"2432944909","title":"中国银河：给予迪安诊断买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2432944909","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432944909?lang=zh_cn&edition=full","pubTime":"2024-05-03 15:50","pubTimestamp":1714722624,"startTime":"0","endTime":"0","summary":"中国银河证券股份有限公司程培,孟熙近期对迪安诊断进行研究并发布了研究报告《2024年一季报业绩点评：减值计提影响表观业绩，一季度业绩低于预期》，本报告对迪安诊断给出买入评级，当前股价为14.1元。最新盈利预测明细如下：该股最近90天内共有6家机构给出评级，买入评级6家；过去90天内机构目标均价为19.41。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024050300003330.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300244","601881"],"gpt_icon":0},{"id":"2430784071","title":"图解迪安诊断一季报：第一季度单季净利润同比减85.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430784071","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430784071?lang=zh_cn&edition=full","pubTime":"2024-04-27 02:20","pubTimestamp":1714155606,"startTime":"0","endTime":"0","summary":"证券之星消息，迪安诊断2024年一季报显示，公司主营收入29.73亿元，同比下降8.01%；归母净利润2317.05万元，同比下降85.54%；扣非净利润2353.63万元，同比下降83.01%；负债率44.5%，投资收益-192.5万元，财务费用5088.81万元，毛利率25.53%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042700004047.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300244"],"gpt_icon":0},{"id":"2430056275","title":"迪安诊断(300244.SZ)发布一季度业绩，净利润2317.05万元，下降85.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430056275","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430056275?lang=zh_cn&edition=full","pubTime":"2024-04-26 20:19","pubTimestamp":1714133970,"startTime":"0","endTime":"0","summary":"智通财经APP讯，迪安诊断(300244.SZ)发布2024年第一季度报告，该公司营业收入为29.73亿元，同比减少8.01%。归属于上市公司股东的净利润为2317.05万元，同比减少85.54%。归属于上市公司股东的扣除非经常性损益的净利润为2353.63万元，同比减少83.01%。基本每股收益为0.0371元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1112225.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300244"],"gpt_icon":0},{"id":"2430869276","title":"迪安诊断最新公告：一季度净利润2317.05万元 同比下降85.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430869276","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430869276?lang=zh_cn&edition=full","pubTime":"2024-04-26 20:09","pubTimestamp":1714133395,"startTime":"0","endTime":"0","summary":"迪安诊断公布2024年一季度报告，报告期营业收入29.73亿元，同比下降8.01%；归属于上市公司股东的净利润2317.05万元，同比下降85.54%；归属于上市公司股东的扣除非经常性损益的净利润2353.63万元，同比下降83.01%；基本每股收益0.0371元。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600051017.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300244"],"gpt_icon":0},{"id":"2429183246","title":"信达证券发布迪安诊断研报，夯实产品能力，ICL实现17%稳健增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2429183246","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429183246?lang=zh_cn&edition=full","pubTime":"2024-04-23 07:35","pubTimestamp":1713828900,"startTime":"0","endTime":"0","summary":"信达证券04月22日发布迪安诊断（300244.SZ，最新价：14.36元）研报称：1）检测项目持续丰富助力ICL业务稳健增长，试点海外市场有望贡献新增量；2）夯实产品能力，强化“产品+服务”医学诊断整体化解决方案提供能力。风险提示：自产产品推广上量不及预期风险；渠道业务集采风险；诊断服务业务中特检业务占比提升进度不及预期风险。（文章来源：每日经济新闻）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042307455287a32235&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042307455287a32235&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0276","BK0114","BK0236","BK0070","BK0042","300244","601059","BK0197","BK0146","BK0028","BK0186"],"gpt_icon":0},{"id":"2428501896","title":"迪安诊断(300244.SZ)发布2023年度业绩，净利润3.07亿元，下降78.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428501896","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428501896?lang=zh_cn&edition=full","pubTime":"2024-04-19 22:19","pubTimestamp":1713536340,"startTime":"0","endTime":"0","summary":"迪安诊断发布2023年年度报告，报告期内，公司实现营业收入134.08亿元，同比下降33.89%。实现归属于上市公司股东的净利润3.07亿元，同比下降78.56%。基本每股收益为0.4918元。拟向全体股东每10股派发现金红利0.60元(含税)。报告期内，诊断服务业务实现营业收入51.87亿元，较去年同口径同比增长11.91%。股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-19/doc-inaskrrs5189873.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-19/doc-inaskrrs5189873.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300244"],"gpt_icon":0},{"id":"2407580348","title":"迪安诊断(300244.SZ)实控人陈海斌提议斥1亿元至2亿元实施回购","url":"https://stock-news.laohu8.com/highlight/detail?id=2407580348","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2407580348?lang=zh_cn&edition=full","pubTime":"2024-01-31 18:50","pubTimestamp":1706698200,"startTime":"0","endTime":"0","summary":"迪安诊断(300244.SZ)公告，公司收到公司实际控制人、董事长陈海斌《关于提议回购公司股份的函》。陈海斌提议公司以自有资金回购公司已发行的部分A股，并在未来适宜时机将回购股份用于股权激励或员工持股计划。回购股份的资金总额不低于1亿元(含)，不超过2亿元(含)。回购期限自公司董事会审议通过回购方案之日起12个月内。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-31/doc-inafmpiw1450189.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-01-31/doc-inafmpiw1450189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0146","BK0042","BK0070","300244","BK0236","BK0186","BK0197","BK0114","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2011-07-19","address":"浙江省杭州市西湖区三墩镇金蓬街329号2幢5层","stockEarnings":[{"period":"1week","weight":0.0217},{"period":"1month","weight":-0.0572},{"period":"3month","weight":-0.3047},{"period":"6month","weight":-0.4698},{"period":"1year","weight":-0.4971},{"period":"ytd","weight":-0.446}],"companyName":"迪安诊断技术集团股份有限公司","boardCode":"AI0083","perCapita":"14875股","boardName":"卫生","registeredCapital":"62689万元","compareEarnings":[{"period":"1week","weight":-0.0061},{"period":"1month","weight":-0.028},{"period":"3month","weight":-0.0072},{"period":"6month","weight":0.0306},{"period":"1year","weight":-0.0677},{"period":"ytd","weight":0.0194}],"survey":"　　迪安诊断技术集团股份有限公司的主营业务是医学诊断服务及体外诊断产品销售。公司的主要产品及服务是医学诊断服务、诊断技术研发、诊断产品生产及销售、CRO、司法鉴定、健康管理。2023 年，公司获得了浙江省人民政府质量奖等荣誉。","serverTime":1718611110186,"listedPrice":23.5,"stockholders":"33807人(较上一季度增加19.43%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.23.1","shortVersion":"4.23.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迪安诊断(300244)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迪安诊断(300244)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迪安诊断,300244,迪安诊断股票,迪安诊断股票老虎,迪安诊断股票老虎国际,迪安诊断行情,迪安诊断股票行情,迪安诊断股价,迪安诊断股市,迪安诊断股票价格,迪安诊断股票交易,迪安诊断股票购买,迪安诊断股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迪安诊断(300244)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迪安诊断(300244)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}